This Modified Stainless Steel Could Kill Bacteria Without Antibiotics or Chemicals

Researchers etch nano-sized textures and add copper ions to create a naturally antibacterial material for hospitals and other shared settings.

Family Loss Brings About Medical Breakthrough

Family tragedy changed Hong Yeo’s life, with his new direction leading to a new potentially lifesaving medical device.

Flicker Stimulation Shines in Clinical Trial for Epilepsy

Biomedical engineer Annabelle Singer has spent the past decade developing a noninvasive therapy for Alzheimer’s disease that also could benefit patients with a host of other neurological disorders, from epilepsy to multiple sclerosis.

Georgia Tech Partners With Children’s Hospital on New Heart Surgery Planning Tool

Cardiologists and surgeons could soon have a new mobile augmented reality (AR) tool to improve collaboration in surgical planning.

Science Square Ushers in New Era of Research

First phase of innovation district promises to encourage medical advances, drive economic growth, and inspire future generations

Cellular Study Uncovers 'Whole-Body' Impacts of Endurance Exercise

Exercise is good for you. To understand why, MoTrPAC scientists are creating a whole-body map of molecular responses to endurance training — finding striking “all tissue effects” in a new set of studies, featured on the May cover of the journal Nature.

New Science and Medical Research Hub Opens in Atlanta

Trammell Crow Company delivers first phase of Georgia Tech district devoted to advancing sciences that improve the human condition

Neurotech Moonshot: Georgia Tech Researcher Shares Impact of BRAIN Initiative in Congressional Briefing

Chris Rozell traveled to Washington, D.C. to share the impacts of the past decade of brain research funded by the NIH BRAIN Initiative with Congress — and share with local representatives how Georgia Tech is playing a key role in leading the charge.

Georgia Tech Researchers Identify Novel Gene Networks Associated with Aggressive Type of Breast Cancer

The team used a computational math theory to identify gene-gene interactions that may be good targets for treating basal-like cancers that are resistant to traditional hormone therapies.

NIH awards $2.9M to Annoviant to advance heart disease technology

Grant is third NIH award for health technology startup.